Dow Up0.26% Nasdaq Down1.07%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
31.95 Down 0.51(1.57%) 4:00PM EDT
|After Hours : 31.95 Down 0.00 (0.01%) 4:43PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 36,014   26,973   24,495   16,330  
Cost of Revenue4,158  2,664  2,359  1,750  
Gross Profit 31,856   24,309   22,136   14,580  
Operating Expenses
Research Development8,942  7,904  8,503  7,892  
Selling General and Administrative32,329  31,778  27,170  18,843  
Non Recurring1  1  1  1  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,416) (15,374) (13,538) (12,156)
Income from Continuing Operations
Total Other Income/Expenses Net(31)(107)228  (47)
Earnings Before Interest And Taxes(9,447)(15,481)(13,310)(12,203)
Interest Expense70  71  359  100  
Income Before Tax(9,517)(15,552)(13,669)(12,303)
Income Tax Expense105  224  183  164  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(9,622)(15,776)(13,852)(12,467)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (9,622) (15,776) (13,852) (12,467)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (9,622) (15,776) (13,852) (12,467)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.